Two Sigma Securities, LLC Genetic Technologies LTD Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.7 - $0.93 $656 - $872	938 Added 6.29%	15,844 $12,000
Q2 2023 Aug 14, 2023	BUY	$0.8 - $1.13 $3,705 - $5,234	4,632 Added 45.08%	14,906 $12,000
Q1 2023 May 15, 2023	BUY	$0.86 - $1.82 $8,835 - $18,698	10,274 New	10,274 $11,000
Q2 2022 Aug 15, 2022	BUY	$0.0 - $0.01 $0 - $116	11,681 New	11,681 $14,000
Q1 2022 May 16, 2022	SELL	$0.0 - $0.0 $0 - $0	-10,090 Closed	0 $0

Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.01 $0 - $100	10,090 New	10,090 $19,000
Q2 2021 Aug 16, 2021	SELL	$0.0 - $0.02 $0 - $473	-23,686 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.0 - $0.01 $0 - $236	23,686 New	23,686 $99,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $21.1M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.